Landfar Bio-medicine Co., Ltd. Class A
000504.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.89B
Close$
$14.98
53.5% upside
Current Fair Value
53.5% upsideUndervalued by 53.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.89 Billion |
|---|---|
| Enterprise Value | $4.02 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | 0.39 |
| Outstanding Shares | 330,023,098 |
Return
| Return on Equity | 14.10% |
|---|---|
| Return on Assets | 4.35% |
| Return on Invested Capital | 4.79% |
Valuation & Multiples
| P/E Ratio | 100.77 |
|---|---|
| PEG | 33.2 |
| Price to Sales | 4.88 |
| Price to Book Ratio | 9.76 |
| Enterprise Value to Revenue | 6.09 |
| Enterprise Value to EBIT | 187.89 |
| Enterprise Value to Net Income | 105 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 1.62 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Landfar Bio-medicine Co., Ltd. Class A
316 employees
CEO: Chang Qiao You Landfar Bio-medicine Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It also involves in the storage of biological resources, stem cells and immune cells. The company was founded in November 1988 and is headquartered in Changsha, China.